secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001628280-21-021753
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT Q3 revenue $8.7M up 314% YoY; raises FY 2021 guide to $33.0-$33.3M
--------------------------------------------------------------------------

- Total revenue of $8.7M vs. $2.1M in Q3 2020; U.S. system revenue $5.0M vs. $0.6M.
- Net loss of $14.1M; cash and short-term investments $320.5M after $172.4M IPO net proceeds.
- Gross margin 48.9%, up from -1% in Q3 2020 and 42.2% in Q2 2021.
- Full-year 2021 revenue guidance raised to $33.0-$33.3M.
- Cigna adopted positive coverage policy for Aquablation, adding 16M covered lives effective Sept 15, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000162828021021753/0001628280-21-021753-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000162828021021753/prct-20211104.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-021753

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer